EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating Denosumab Interference in Serum Protein Electrophoresis

Sungyu Jee, Jungjun Lee, Hanwool Cho, Hyojin Chae

The Journal of Applied Laboratory Medicine · 04.11.2026 · 11 (6) · 1565-1571

DOI: 10.1093/jalm/jfag135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 08.10.2026. Verfasst von Sungyu Jee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Denosumab, Multiple Myeloma, Blood Protein Electrophoresis, Myeloma Proteins. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic monoclonal antibodies, widely used in multiple myeloma (MM), can interfere with the interpretation of serum protein electrophoresis (SPEP) and immunofixation electrophoresis results, challenging the differentiation from endogenous monoclonal (M) proteins associated with the disease. Although this interference has been well established for several therapeutic monoclonal antibodies, the potential impact of denosumab, an IgG2(κ) antibody used to treat MM-related bone disease, remains unclear.

Methods

We characterized the electrophoretic migration of denosumab using in vitro spiking experiments. To evaluate in vivo interference, we performed a retrospective review of SPEP and immunotyping results from 110 patients with MM receiving denosumab. Finally, we used matrix-assisted desorption/ionization time-of-flight mass spectrometry (using the EXENT system) to distinguish between denosumab and endogenous M-proteins based on molecular mass.

Results

In vitro, denosumab migrated to the mid-to-distal gamma region, nearer the cathodal end than daratumumab, with a normalized migration ratio of approximately 1.34. Among the 110 patients, one exhibited a corresponding IgG(κ) peak on SPEP and immunotyping with the specified migration position, although mass spectrometry confirmed this to be an endogenous M-protein rather than denosumab. No denosumab-specific interference was detected above the lower limit of quantification (15 mg/L) using mass spectrometry.

Conclusions

Although denosumab exhibited a consistent electrophoretic migration pattern in vitro, it did not cause clinically relevant in vivo interference in SPEP or immunotyping assays. These findings support accurate electrophoretic interpretation and reduce concerns regarding misclassification of M-proteins in patients with MM receiving denosumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabMultiple MyelomaBlood Protein ElectrophoresisMyeloma ProteinsHumansRetrospective StudiesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationFemale

Substanzen

DenosumabMyeloma Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, St. Vincent's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea.

Zitieren

APA

Jee, S., Lee, J., Cho, H., & Chae, H. (2026). Investigating Denosumab Interference in Serum Protein Electrophoresis. The Journal of Applied Laboratory Medicine, 11(6), 1565-1571. https://doi.org/10.1093/jalm/jfag135

Vancouver

Jee S, Lee J, Cho H, Chae H. Investigating Denosumab Interference in Serum Protein Electrophoresis. The Journal of Applied Laboratory Medicine. 2026;11(6):1565-1571. doi:10.1093/jalm/jfag135

BibTeX
@article{Jee2026,
  author = {Jee, Sungyu and Lee, Jungjun and Cho, Hanwool and Chae, Hyojin},
  title = {Investigating Denosumab Interference in Serum Protein Electrophoresis},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  volume = {11},
  number = {6},
  pages = {1565--1571},
  doi = {10.1093/jalm/jfag135}
}
Kostenlos starten →